Evaluation of Efficacy and Safety of Agalsidase Beta in Heterozygous Females for Fabry Disease (Q61918311)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Evaluation of Efficacy and Safety of Agalsidase Beta in Heterozygous Females for Fabry Disease |
clinical trial |
Statements
HEART (English)
0 references
A Multicenter, Phase 4, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Recombinant Alpha-Galactosidase A (Agalsidase Beta, FABRAZYME) in Heterozygous Females for Fabry Disease (English)
0 references
June 2005
0 references
34
0 references
15 year
0 references